Trial site
Nanjing Chest Hospital
Nanjing, 210000, ChinaNot linked to an institution yet
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Phase
- Phase 34 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Not yet recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Advenchen Laboratories, LLC1 trial
- Alpha Biopharma (Jiangsu) Co., Ltd.1 trial
- Amgen1 trial
- BeiGene1 trial
- BioNTech SE1 trial
- and 3 more
Running trials
Recruiting
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
NCT07143045· Alpha Biopharma (Jiangsu) Co., Ltd.· Source
Contact: Yu Zhang Professor
Recruiting
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery
NCT07182682· Phase 3· Dizal (Jiangsu) Pharmaceutical Co., Ltd.· Source
Contact: Sherry Hu, MD, PhD
Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
NCT06892548· Phase 1/2· BioNTech SE· Source
Active, not recruiting
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab
NCT06211036· Phase 3· Amgen· Source
Active, not recruiting
A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
NCT05047250· Phase 3· Hoffmann-La Roche· Source
Active, not recruiting
A Study of AL8326 in Non-Small Cell Lung Cancer
NCT06794957· Phase 1· Advenchen Laboratories, LLC· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error